Revance Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-24-000071 |
2024-03-21 16:06:49 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-23-000049 |
2023-03-23 16:05:49 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-22-000048 |
2022-03-24 16:07:57 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-21-000089 |
2021-03-24 17:20:20 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-21-000076 |
2021-03-11 17:11:59 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-20-000048 |
2020-03-26 17:04:22 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-19-000041 |
2019-03-25 16:26:32 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-18-000056 |
2018-03-20 17:05:56 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-17-000019 |
2017-03-24 16:58:27 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001479290-16-000034 |
2016-03-18 16:09:43 |
DEF 14A
|
| 1479290 |
RVNC |
Revance Therapeutics, Inc. |
0001628280-15-001990 |
2015-03-26 16:12:08 |
DEF 14A
|
